Steven R. Grossman

10.3k citations

102 papers · 7.8k indexed · 2 hit papers · h-index 45

Molecular Biology top 1%
Oncology top 0.5%
Genetics top 2%
Epidemiology top 5%
Cancer Research top 2%

Co-authors: David M. Livingston Laimonis A. Laimins James A. DeCaprio Doron Ginsberg Nancy L. Lill Andrew L. Kung Dingding Shi Chrystelle Brignone
Topics: Cancer-related Molecular Pathways (33 papers)Cancer-related gene regulation (22 papers)Kruppel-like factors research (21 papers)
Cited by: Oncology Molecular Biology Cancer Research
Journals: Nature Science Cell
Partner nations: United States Canada Germany

In The Last Decade

Steven R. Grossman

101 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Binding and modulation of p53 by p300/CBP coactivators

1997 592 citations Steven R. Grossman, James A. DeCaprio et al. profile →
BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function

2001 541 citations Steven R. Grossman et al. profile →

Peers

Countries citing papers authored by Steven R. Grossman

Since Specialization

Citations

This map shows the geographic impact of Steven R. Grossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven R. Grossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven R. Grossman more than expected).

Fields of papers citing papers by Steven R. Grossman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven R. Grossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven R. Grossman. The network helps show where Steven R. Grossman may publish in the future.

Co-authorship network of co-authors of Steven R. Grossman

This figure shows the co-authorship network connecting the top 25 collaborators of Steven R. Grossman. A scholar is included among the top collaborators of Steven R. Grossman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven R. Grossman. Steven R. Grossman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oncogenic Mutant p53 Sensitizes Non–Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress–Dependent Induction of Mitochondrial Apoptosis 2024 ·Cancer Research Communications ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Jennifer E. Koblinski,(unknown),Swati Palit Deb,(unknown),Jorge J. Nieva,Senthil K. Radhakrishnan,Hisashi Harada,Steven R. Grossman	3
2	Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis 2024 ·Cancer Letters ·Tiantian Zhang,Sha Li,(unknown),Xiang Chen,(unknown),Zhengming Chen,(unknown),(unknown),Soyoung Choi,Sandra J. Shin,Priyadarshan K. Damle,(unknown),Steven R. Grossman,Dunrui Wang,Xuejun Jiang,Yi Li,Erika Hissong,Yao‐Tseng Chen,Jenny Xiang,Yi‐Chieh Nancy Du	0
3	ADCC's Improving Goal Concordant Care Initiative: Implementing Primary Palliative Care Principles 2023 ·Journal of Pain and Symptom Management ·Elizabeth T. Loggers,Amy A. Case,Marcin Chwistek,William Dale,Marvin Omar Delgado-Guay,Stephen B. Edge,Steven R. Grossman,Jillian Gustin,Judith E. Nelson,(unknown),Akhila Reddy,James A. Tulsky,Finly Zachariah,Kristen K. McNiff	4
4	Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promising Novel Therapy for Pancreatic Cancer 2023 ·Cancer Research Communications ·M. Michael Dcona,(unknown),(unknown),(unknown),(unknown),Keith C. Ellis,Steven R. Grossman	2
5	Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma 2023 ·Oncogenesis ·(unknown),(unknown),Priyadarshan K. Damle,(unknown),Bo Cheng,M. Michael Dcona,Barbara Szomju,Mikhail G. Dozmorov,Michael O. Idowu,Steven R. Grossman	1
6	Cell competition in intratumoral and tumor microenvironment interactions 2021 ·The EMBO Journal ·Taylor M. Parker,Kartik Gupta,Antonio Palma,Michail Yekelchyk,Paul B. Fisher,Steven R. Grossman,Kyoung‐Jae Won,Esha Madan,Eduardo Moreno,Rajan Gogna	62
7	Extraction of high-quality RNA from mouse pancreatic tumors 2020 ·MethodsX ·(unknown),Steven R. Grossman	4
8	Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer 2019 ·Advances in Radiation Oncology ·Emma C. Fields,Brian Kaplan,Jeremy Karlin,(unknown),Nitai D. Mukhopadhyay,Xiaoyan Deng,Heidi Sankala,Steven R. Grossman,Khalid Matin	3
9	Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells 2017 ·Molecular Oncology ·Catherine A. Vaughan,Shilpa Singh,Steven R. Grossman,Brad E. Windle,Swati Palit Deb,Sumitra Deb,(unknown),(unknown)	14
10	Clinic Blood Pressure Underestimates Ambulatory Blood Pressure in an Untreated Employer-Based US Population 2016 ·Circulation ·Joseph E. Schwartz,Matthew M. Burg,Daichi Shimbo,Joan E. Broderick,Arthur A. Stone,Joji Ishikawa,Richard P. Sloan,(unknown),Steven R. Grossman,Thomas G. Pickering	60
11	Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination 2016 ·Molecular Cancer Research ·(unknown),Ian M. Love,Priyadarshan K. Damle,Nitai D. Mukhopadhyay,Swati Palit Deb,Sumitra Deb,Steven R. Grossman	14
12	Pancreatic Cancer–Specific Cell Death Induced In Vivo by Cytoplasmic-Delivered Polyinosine–Polycytidylic Acid 2014 ·Cancer Research ·Praveen Bhoopathi,Bridget A. Quinn,Qin Gui,Xue‐Ning Shen,Steven R. Grossman,Swadesh K. Das,Devanand Sarkar,Paul B. Fisher,Luni Emdad	34
13	The ARF Tumor Suppressor Inhibits Tumor Cell Colonization Independent of p53 in a Novel Mouse Model of Pancreatic Ductal Adenocarcinoma Metastasis 2011 ·Molecular Cancer Research ·(unknown),J. Matthew Barnes,Seema Paliwal,Xuefeng Zhang,Xiaoyun Tang,Songhai Chen,K. D. Zamba,Joseph J. Cullen,David K. Meyerholz,Shari Meyers,J. Nathan Davis,Steven R. Grossman,Michael D. Henry,Dawn E. Quelle	24
14	Mdm2 facilitates the association of p53 with the proteasome 2010 ·Proceedings of the National Academy of Sciences ·R. Kulikov,(unknown),Manjit Kaur,Steven R. Grossman,Janine Arts,Christine Blattner	62
15	p19Arf Inhibits the Invasion of Hepatocellular Carcinoma Cells by Binding to C-terminal Binding Protein 2008 ·Cancer Research ·Ya‐Wen Chen,Seema Paliwal,Kyle Draheim,Steven R. Grossman,Brian C. Lewis	48
16	Spontaneous Expression of Embryonic Factors and p53 Point Mutations in Aged Mesenchymal Stem Cells: A Model of Age-Related Tumorigenesis In Mice 2007 ·Cancer Research ·Hanchen Li,Xueli Fan,Ramesh C. Kovi,Yunju Jo,(unknown),(unknown),Calin Stoicov,Evelyn A. Kurt‐Jones,Steven R. Grossman,(unknown),Arlin B. Rogers,Marshall H. Montrose,JeanMarie Houghton	155
17	Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features 2007 ·Comprehensive Psychiatry ·Tom Craig,Steven R. Grossman,Evelyn J. Bromet,Laura J. Fochtmann,Gabrielle A. Carlson	7
18	A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway 2004 ·Oncogene ·Chrystelle Brignone,(unknown),Alexei F. Kisselev,Steven R. Grossman	55
19	Cells Degrade a Novel Inhibitor of Differentiation with E1A-Like Properties upon Exiting the Cell Cycle 2000 ·Molecular and Cellular Biology ·Satoshi Miyake,William R. Sellers,Michal Safran,Xiaotong Li,Wenqing Zhao,Steven R. Grossman,(unknown),James A. DeCaprio,Peter D. Adams,William G. Kaelin	94
20	BVRT - scoring system and time delay in the differentiation of lateralized hemispheric damage 1989 ·Eli Vakil,Haya Blachstein,(unknown),Steven R. Grossman	5

About Steven R. Grossman

Steven R. Grossman is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 102 papers that have together received 7.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (33 papers), Cancer-related gene regulation (22 papers) and Kruppel-like factors research (21 papers). The work is most often cited by research in Oncology (2.9k citations), Molecular Biology (4.8k citations) and Cancer Research (908 citations). Steven R. Grossman has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include David M. Livingston, Laimonis A. Laimins, James A. DeCaprio, Doron Ginsberg, Nancy L. Lill, Andrew L. Kung, Dingding Shi, Chrystelle Brignone, Arthur A. Stone and Joseph E. Schwartz. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact